EGFR and hepatocellular carcinoma: Gefitinib induced rapid inactivation of EGFR, AKT, and ERK, and a dramatic increase of BIM in both HCC827 with an empty vector (HCC827/Emp) and HCC/Del cells (Figure 3A).